Drugs.com - Pharma Industry News

Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide

WEDNESDAY, Feb. 26, 2025 -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online Feb. 20 in JAMA...

Feb 26, 2025 - 18:25
 0
Nonarteritic Anterior Ischemic Optic Neuropathy Increased With Semaglutide
WEDNESDAY, Feb. 26, 2025 -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online Feb. 20 in JAMA...
Read More

Tags:

Previous Article

Machine Learning May Predict Progression to Serious Mental Illness

Next Article

Behavioral, Developmental Disorders in Children More Common in Recent Years

Related Posts

Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC

Dual-Targeted Therapies Plus Chemo Improve Objective Re...

Feb 9, 2025  0

Live Birth Rate Lower With Frozen Versus Fresh Embryo Transfer

Live Birth Rate Lower With Frozen Versus Fresh Embryo T...

Feb 9, 2025  0

Use of Secondary CVD Prevention Medications Low in Most Countries

Use of Secondary CVD Prevention Medications Low in Most...

Feb 12, 2025  0